Sun Pharmaceutical Industries Ltd.

  • Value Research Rating market-capitalisation-info
    4 star
  • Market Capitalisation market-capitalisation-info ₹3,80,451 Cr
  • Price to Earnings Ratio price-to-earning 39.73
  • 12 Month Earnings monthly-earning ₹9,648 Cr
Value Research Rating
4 star
Quality Score fund-quick-summary-circle
8/10
Growth Score fund-quick-summary-circle
8/10
Valuation Score fund-quick-summary-circle
5/10

Sun Pharmaceutical Industries Ltd. Share Price

₹1,586.20

As on 15-Jul-2024 IST

up-down-arrow8.900.56%

  • Prev Close info

    1,577.30

  • Day's Openinfo

    1,579.95

  • Today's Highinfo

    1,594.70

  • Today's Lowinfo

    1,577.30

  • Today's Volumeinfo

    8,32,804

  • 52 Week rangeinfo

    ₹1,063.85 - 1,638.85

Please wait...

Stock Range

Today’s Range
Low 1,577.30 High: 1,594.70
52 Week Range
Low 1,063.85 High: 1,638.85
Liquidity
Low High

Sun Pharmaceutical Industries Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sun Pharmaceutical
25.94 4.63 3.00 47.84 32.24 31.22 7.95
BSE Sensex
11.66 4.77 8.65 22.11 15.10 15.80 12.42
BSE Healthcare
22.92 3.96 9.98 47.85 14.17 24.58 12.76
As on 15-Jul-2024
2023
2022
2021
2020
2019
2018
2017
Sun Pharmaceutical
25.77 18.41 41.84 36.39 -0.23 -25.01 -9.34
BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Essential Checks

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Sun Pharmaceutical Industries Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Sun Pharmaceutical Industries Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Sun Pharmaceutical Industries Ltd.

        Other details of Sun Pharmaceutical Industries Ltd.

        Incorporated

        1993

        Chairman

        Dilip S Shanghvi

        Managing Director

        Dilip S Shanghvi

        Group

        Sun Pharma

        Headquarters

        Vadodara, Gujarat

        FAQs for Sun Pharmaceutical Industries Ltd.

        The total asset value of Sun Pharmaceutical Industries Ltd stood at ₹ 85,308 Cr as on 31-Mar-24

        The share price of Sun Pharmaceutical Industries Ltd is ₹1,586.20 (NSE) and ₹1,585.65 (BSE) as of 15-Jul-2024 IST. Sun Pharmaceutical Industries Ltd has given a return of 32.24% in the last 3 years.

        Sun Pharmaceutical Industries Ltd has a market capitalisation of ₹ 3,80,451 Cr as on 15-Jul-2024. As per Value Research classification, it is a Large Cap company.

        The P/B ratio of Sun Pharmaceutical Industries Ltd is 5.98 times as on 15-Jul-2024, a 1% premium to its peers’ median range of 5.95 times.

        The P/E ratio of Sun Pharmaceutical Industries Ltd is 39.73 times as on 15-Jul-2024, a 1% discount to its peers’ median range of 40.26 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Sun Pharmaceutical Industries Ltd and enter the required number of quantities and click on buy to purchase the shares of Sun Pharmaceutical Industries Ltd.

        Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

        The promoters of Sun Pharmaceutical Industries Ltd are Shanghvi Finance Private Limited and Dilip. S. Shanghvi. They collectively own 49.9 per cent of the total equity. The chairman of the company is Dilip S Shanghvi

        The promoters of Sun Pharmaceutical Industries Ltd have pledged 1.12% of the total equity as on Mar-24.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        1,22,098
        1,18,217
        1,12,137
        99,824
        Sun Pharmaceutical Industries Ltd. Ratios
        Return on equity(%)
        16.13
        Operating margin(%)
        21.02
        Net Margin(%)
        19.25
        Dividend yield(%)
        0.83

        Yes, TTM profit after tax of Sun Pharmaceutical Industries Ltd was ₹9,648 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹3,80,450.55 Cr
        • Revenue (TTM)revenue-information ₹48,496.85 Cr
        • Earnings (TTM) earning-information ₹9,648.44 Cr
        • Cash date-information ₹19,105.22 Cr
        • Total Debt info ₹2,845.69 Cr
        • Promoters' ownership promoters_ownership 54.48%
        • Liquidity liquidity High
        • 52 Week range week-range ₹1,063.85 - 1,638.85
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 2,39,93,34,970
        • 10 Years Aggregate:

          CFO: ₹64,291.40 Cr

          EBITDA: ₹87,158.11 Cr

          Net Profit: ₹52,845.20 Cr

        About The Company

        • Incorporated 1993
        • Chairman Dilip S Shanghvi
        • Managing Director Dilip S Shanghvi
        • Group Sun Pharma
        • Listing key-listing BSE: 524715, NSE: SUNPHARMA
        • Country India
        • Headquarters headquarters Vadodara, Gujarat
        • Website website www.sunpharma.com
        • Business

          Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations...  in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.  Read more